BPA Call W81K0020A0014-W81K0023F0135
Award Date
10/1/23
Potential Completion Date
9/30/24
Potential Value
$75K
Funding Federal Agency
Defense Health Agency
Contracting Federal Agency
Medical Command
Awardee
Pharmalucence, Inc.
Ultimate Awardee
Not listed
NAICS Category
325412 - Pharmaceutical Preparation Manufacturing
PSC Category
6505 - Drugs And Biologicals
Set-Aside Type
No Set-Aside Used
Federal Contract Vehicle
Extent Competed
Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
El Paso, TX 79918, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm fixed-price blanket purchase agreement (BPA) call contract awarded by the Defense Health Agency (DHA), a component of the Department of Defense, to Pharmalucence, Inc. for the supply of various radiopharmaceuticals. The $100,000.00 contract has an ultimate completion date of September 30, 2025 and does not have a set-aside designation. Pharmalucence, Inc. is a specialty pharmaceutical company focused on manufacturing and distributing generic radiopharmaceutical products and...
This is a firm fixed-price purchase order awarded by the Defense Health Agency (DHA), a component of the Department of Defense, to Pharmalucence, Inc., a specialty pharmaceutical manufacturer. The $17,447 contract is for the delivery of molecular imaging products for nuclear medicine, specifically Pharmalucence's SC05 Sulfur Colloid radiopharmaceutical kits. The contract has no set-aside designation, indicating open competition. Pharmalucence, Inc. is a for-profit, Subchapter S Corporation...
This contract award to Lantheus Medical Imaging, Inc. is a Blanket Purchase Agreement (BPA) call from the Defense Health Agency (DHA) for the delivery of radiopharmaceuticals. The contract has a ceiling value of $15,000.00 and a completion date of September 30, 2024. It is a firm fixed-price contract for the provision of critical nuclear medicine supplies and diagnostic imaging agents, primarily used in medical imaging procedures at military treatment facilities, VA medical centers, and other...
This is a $375,785.71 fixed-price with economic price adjustment purchase order contract awarded to Lantheus Medical Imaging, Inc. by the Defense Health Agency (DHA) for the procurement of radiopharmaceutical diagnostic products. The contract is set aside for small businesses and has an ultimate completion date of December 31, 2014. Lantheus Medical Imaging, a for-profit manufacturer of diagnostic medical imaging agents and products, is the prime contractor. The contract is part of a larger...
This federal contract award, valued at $250,000.00, was issued by the Defense Health Agency (DHA) to Lantheus Medical Imaging, Inc., a for-profit manufacturer of diagnostic medical imaging agents and radiopharmaceutical products. The contract covers the provision of various radiopharmaceuticals, with a period of performance through September 30, 2024. This award is part of a larger Blanket Purchase Agreement (BPA) that Lantheus Medical Imaging holds with the DHA, valued at $6.5 million and...
This is a $150,000 Blanket Purchase Agreement (BPA) call awarded by the Defense Health Agency (DHA) to Curium US LLC, a foreign-owned, for-profit manufacturer of radiopharmaceuticals. The contract provides firm fixed price deliveries of various radiopharmaceutical products and services to support healthcare operations at military medical facilities, including Walter Reed National Military Medical Center. The contract has a period of performance through September 30, 2025 and no set-aside...
The Defense Health Agency awarded a firm fixed price Blanket Purchase Agreement (BPA) call to Medi-Physics, Inc. (doing business as GE Healthcare), a subsidiary of General Electric Company, to provide radiopharmaceuticals. The $50,050 contract has a completion date of September 30, 2023. Medi-Physics is a manufacturer of specialized pharmaceutical products used in nuclear medicine procedures, including radioactive tracers for positron emission tomography (PET) scans and single-photon emission...
This federal contract award to Lantheus Medical Imaging, Inc., a subsidiary of Lantheus Holdings, Inc., is for the delivery of radiopharmaceuticals and supplies to the Defense Health Agency (DHA). The $99,986.35 firm fixed-price contract has an ultimate completion date of September 30, 2025. Lantheus Medical Imaging, Inc. has secured multiple Indefinite Delivery Vehicles (IDVs) with the DHA, including a $6.5 million single-award Blanket Purchase Agreement (BPA) for diagnostic nuclear imaging...
This federal contract award is for radiopharmaceuticals and supplies, with a ceiling value of $100,000.00. The contract was awarded to Medi-Physics, Inc., a subsidiary of General Electric Company, and does not have a small business set-aside designation. Medi-Physics, Inc. is a manufacturer of specialized pharmaceutical products used in nuclear medicine procedures, with a focus on radiopharmaceuticals like DATSCAN (ioflupane I-123) for diagnostic imaging. The contract is a Blanket Purchase...
This is a firm fixed-price purchase order awarded by the Department of the Army Medical Command to Pharmalucence, Inc., a for-profit manufacturer of pharmaceutical goods and medical supplies, for the delivery of radiopharmaceutical supplies, specifically sulfur colloid. The contract has a potential value of $162,030 and a period of performance ending on September 30, 2018. This award does not have a set-aside designation. Pharmalucence is an international, integrated, specialty pharmaceutical...